These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31637192)
1. Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma. Muhsen S; Compan J; Lai T; Kranemann C; Birt C Int J Ophthalmol; 2019; 12(10):1567-1574. PubMed ID: 31637192 [TBL] [Abstract][Full Text] [Related]
2. Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study. Kandarakis S; Kontaxakis A; Doumazos L; Petrou P; Droutsas K; Papaconstantinou D; Georgalas I Cutan Ocul Toxicol; 2022 Mar; 41(1):25-32. PubMed ID: 34749555 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study. Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279 [TBL] [Abstract][Full Text] [Related]
4. Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs. Tai TY; Moster MR; Pro MJ; Myers JS; Katz LJ J Glaucoma; 2015; 24(4):311-5. PubMed ID: 25826644 [TBL] [Abstract][Full Text] [Related]
5. Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs. Simsek T; Cankaya AB; Elgin U J Ocul Pharmacol Ther; 2012 Oct; 28(5):542-6. PubMed ID: 22731246 [TBL] [Abstract][Full Text] [Related]
6. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study. Akkan JU; Cilsim S J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044 [TBL] [Abstract][Full Text] [Related]
7. Delayed post-operative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma. Mastropasqua L; Carpineto P; Ciancaglini M; Zuppardi E; Lobefalo L; Gallenga PE Eye (Lond); 1998; 12 ( Pt 4)():701-6. PubMed ID: 9850268 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial. Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038 [TBL] [Abstract][Full Text] [Related]
9. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Nilforushan N; Yadgari M; Kish SK; Nassiri N Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Grewal DS; Jain R; Kumar H; Grewal SP Ophthalmology; 2008 Dec; 115(12):2141-2145.e2. PubMed ID: 18692246 [TBL] [Abstract][Full Text] [Related]
11. Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy. Freiberg FJ; Matlach J; Grehn F; Karl S; Klink T Clin Ophthalmol; 2013; 7():1211-7. PubMed ID: 23814458 [TBL] [Abstract][Full Text] [Related]
12. Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery. Saeed AM; AboulNasr TT Clin Ophthalmol; 2014; 8():1745-55. PubMed ID: 25246758 [TBL] [Abstract][Full Text] [Related]
13. The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model. Ozgonul C; Mumcuoglu T; Gunal A Curr Eye Res; 2014 May; 39(5):451-9. PubMed ID: 24215335 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550 [TBL] [Abstract][Full Text] [Related]
15. Randomized, controlled trial of a sustained delivery formulation of 5-fluorouracil for the treatment of failing blebs. Narayanaswamy AK; Lee K; Zhen M; Chua J; Chai SM; Boey PY; Zheng C; Aung T; Venkatraman S; Wong TT Ophthalmology; 2012 Feb; 119(2):314-20. PubMed ID: 22153707 [TBL] [Abstract][Full Text] [Related]
16. Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma. Mahdy RA; Al-Mosallamy SM; Al-Aswad MA; Bor'i A; El-Haig WM Eye (Lond); 2016 Jan; 30(1):53-8. PubMed ID: 26427987 [TBL] [Abstract][Full Text] [Related]
17. Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab. Nilforushan N; Es'haghi A; Miraftabi A; Abolfathzadeh N; Banifatemi M Br J Ophthalmol; 2022 May; 106(5):648-654. PubMed ID: 33328187 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Efficacy and Safety of Bleb Needle Revision With and Without 5-Fluorouracil for Failing Trabeculectomy Bleb. Kim JS; Kim HJ; Na KI; Kim YK; Park KH; Jeoung JW J Glaucoma; 2019 May; 28(5):386-391. PubMed ID: 30839411 [TBL] [Abstract][Full Text] [Related]
20. A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy. O'Brart DP; Rowlands E; Islam N; Noury AM Br J Ophthalmol; 2002 Jul; 86(7):748-54. PubMed ID: 12084743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]